Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3989614 | Journal of Thoracic Oncology | 2015 | 9 Pages |
Abstract
The majority of rare EGFR mutations was associated with smoking, shorter overall survival, and decreased TKI response when compared with classic EGFR mutations. However, studies characterizing the TKI sensitizing effect of individual rare mutations are indispensable to prevent the exclusion of patients with sensitizing rare EGFR mutations who may benefit from anti-EGFR therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zoltan MD, Mir Alireza MD, Katalin MD, Gyula MD, PhD, Erzsebet PhD, Tamas MS, Jozsef MD, PhD, DSc, Ilona MD, PhD, Mihaly MS, Anita MS, Viktoria PhD, Michael PhD, Walter PhD, Walter MD, Judit MD, PhD, Balazs MD, PhD, Balazs PhD,